Pharmacists in Cleona, PA Accepting Medicare
3 Pharmacists found. Showing 1 - 3
 Mrs. Bindu George Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 469 W Penn Ave, Cleona, PA 17042 Phone: 717-228-2289 Fax: 717-228-2310 |
Meggan Sivik Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 469 W Penn Ave, Cleona, PA 17042 Phone: 717-228-2289 |
Dr. Ashley Palkovic, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 469 W Penn Ave, Cleona, PA 17042 Phone: 717-228-2289 |
News Archive
MDMA (Ecstasy) holds promise for chronic treatment-resistant PTSD
MDMA (-3,4-methylenedioxymethamphetamine, also known as Ecstasy), may one day offer hope for individuals with posttraumatic stress disorder (PTSD), even people for whom other treatments have failed. Clinical trial results out today in the Journal of Psychopharmacology, published by SAGE, suggests that MDMA can be administered to subjects with PTSD without evidence of harm and could offer sufferers a vital window with reduced fear responses where psychotherapy can take effect.
Autism Consortium holds its fourth annual symposium to update on autism
The Autism Consortium, an innovative collaboration of researchers, clinicians, funders and families dedicated to catalyzing research and enhancing clinical care for autism spectrum disorders (ASDs), held its fourth annual symposium on October 28th, 2009, at Harvard Medical School in Boston.
CHI commends FDA's recognition of more efficient regulatory pathway for innovative medical devices
"CHI commends the FDA for its recognition of the need for a more efficient regulatory pathway for innovative medical devices that have the potential to improve lives," said CHI President and CEO David L. Gollaher, Ph.D. "It is essential that the FDA maintains focus on initiatives that strengthen the medical device review process, bringing greater clarity and consistency, while ensuring the U.S. maintains its competitive edge."
Lower dose of thrombolytics can treat moderate pulmonary embolism
Pulmonary embolism - the sudden blockage of an artery in the lung - is estimated to cause over 100,000 deaths each year in the U.S. Although thrombolytics, or "clot-buster" drugs, are currently reserved to treat only the most severe cases of pulmonary embolism, new data suggest that when used at lower doses, these drugs are also safe and effective for more common, moderate cases of pulmonary embolism, according to research presented today at the American College of Cardiology's 61st Annual Scientific Session.
› Verified 8 days ago